We use Drosophila and mouse genetics and cell culture experiments to understand ... We have reported a mouse model for Alagille syndrome (ALGS), a multisystem disorder, which predominantly affects ...
is labelled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow – in children aged six months and over with ALGS, a disease caused by a genetic mutation ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
3d
Zacks Investment Research on MSNAligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue EstimatesAligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $3.41 per share versus the Zacks Consensus Estimate of a loss of $1.91. This compares to loss of $5.50 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results